title: Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome.
authors.affiliation: Department of Neurology, Rostock University, Rostock, Germany. dirk.dressler@med.uni-rostock.de
authors.forename: D
authors.initials: D
authors.lastname: Dressler
authors.forename: M
authors.initials: M
authors.lastname: Wittstock
authors.forename: R
authors.initials: R
authors.lastname: Benecke
mesh_terms: D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D020821:Dystonic Disorders / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D007571:Jaw Diseases / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006211:Pantothenate Kinase-Associated Neurodegeneration / Q000150:complications*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A